Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug trial offers hope for advanced cancer patients

NCT ID NCT05470348

Recruiting now Disease control Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests a new drug called BL-B01D1 in 36 adults with advanced breast cancer or other solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for early signs of tumor shrinkage. Participants will be closely monitored for side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER SOLID TUMOR

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fudan University ShangHai Cancer Center

    RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Guangdong Provincial People's Hospital

    RECRUITING

    Guangzhou, Guangdong, China

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.